Related news from  |
Sat, 12 Jul 2025 18:52:40 +0000 |
RBC Capital Maintains a Buy Rating on Dyne Therapeutics (DYN) With a $25 PT
Dyne Therapeutics, Inc. (NASDAQ:DYN) is one of the 13 Best Healthcare Stocks to Buy Under $10. In a report released on July 7, Luca Issi from RBC Capital maintained a Buy rating on Dyne Therapeutics, Inc. (NASDAQ:DYN) with a price target of $25.00. In other news, Dyne Therapeutics, Inc. (NASDAQ:DYN) announced on June 30 that it entered […]
|
Fri, 11 Jul 2025 22:15:02 +0000 |
Hercules Capital (HTGC) Gains As Market Dips: What You Should Know
The latest trading day saw Hercules Capital (HTGC) settling at $18.94, representing a +1.07% change from its previous close.
|
Wed, 02 Jul 2025 22:15:04 +0000 |
Hercules Capital (HTGC) Outperforms Broader Market: What You Need to Know
Hercules Capital (HTGC) closed the most recent trading day at $18.59, moving +1.36% from the previous trading session.
|
Tue, 01 Jul 2025 10:00:00 +0000 |
Hercules Capital Receives Affirmed BBB- Investment Grade Corporate and Unsecured Credit Rating from Fitch Ratings, Inc.
SAN MATEO, Calif., July 01, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Fitch Ratings, Inc. ("Fitch") has affirmed Hercules’ investment grade corporate and unsecured credit rating of BBB- with a stable outlook, as well as its underlying analys
|
Mon, 30 Jun 2025 20:01:00 +0000 |
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced it has entered into a $275 million non-dilutive senior secured term loan facility with Hercules Capital, Inc. (NYSE: HTGC)
|
Tue, 24 Jun 2025 22:15:04 +0000 |
Hercules Capital (HTGC) Surpasses Market Returns: Some Facts Worth Knowing
The latest trading day saw Hercules Capital (HTGC) settling at $18.08, representing a +1.57% change from its previous close.
|
Fri, 20 Jun 2025 13:30:07 +0000 |
Wall Street Analysts Think Hercules Capital (HTGC) Is a Good Investment: Is It?
Based on the average brokerage recommendation (ABR), Hercules Capital (HTGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
|
Wed, 18 Jun 2025 22:00:02 +0000 |
Hercules Capital (HTGC) Ascends While Market Falls: Some Facts to Note
In the latest trading session, Hercules Capital (HTGC) closed at $18.02, marking a +1.24% move from the previous day.
|
Mon, 16 Jun 2025 20:04:00 +0000 |
Hercules Capital Closes Upsized Institutional Notes Offering of $350.0 Million 6.000% Unsecured Notes due 2030
SAN MATEO, Calif., June 16, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), today announced that it has closed an upsized underwritten public offering of $350.0 million in aggregate principal amount of 6.000% notes due June 2030 (the "Notes").
|
Thu, 12 Jun 2025 20:04:00 +0000 |
Hercules Capital Renews and Increases Its Credit Facility with MUFG Bank, Ltd. to $440.0 Million
SAN MATEO, Calif., June 12, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty finance provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has upsized and renewed its existing $400.0 million credit facility with MUFG Bank, Ltd. ("MUFG") with an upsized credit facility under which Goldman Sachs Bank USA, Auto
|
Wed, 11 Jun 2025 21:19:00 +0000 |
Hercules Capital Prices Upsized Institutional Notes Offering of $350.0 Million 6.000% Notes due 2030
SAN MATEO, Calif., June 11, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), today announced that it has priced an upsized underwritten public offering of $350.0 million in aggregate principal amount of 6.000% notes due June 2030 (the "Notes"). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on June 16, 2025.
|
Thu, 22 May 2025 12:50:00 +0000 |
ARCC vs. HTGC: Which BDC Has More Upside Amid Market Uncertainty?
Can tech-focused Hercules Capital outperform diversified Ares Capital in today's uncertain market? Let's find out.
|
Tue, 13 May 2025 11:00:00 +0000 |
Altimmune Secures Up to $100 Million in Credit Facility from Hercules Capital
Term loan adds balance sheet strength and provides financial flexibility to support continued development of pemvidutideGAITHERSBURG, Md., May 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has entered into an agreement with Hercules Capital, Inc. (NYSE: HTGC), a leader in debt financing for life science companies, for up to $100
|
Fri, 09 May 2025 19:02:10 +0000 |
Investing in Hercules Capital (NYSE:HTGC) five years ago would have delivered you a 187% gain
While Hercules Capital, Inc. ( NYSE:HTGC ) shareholders are probably generally happy, the stock hasn't had particularly...
|
Thu, 08 May 2025 16:10:00 +0000 |
Ares Capital Misses on Q1 Earnings: Should You Sell or Hold the Stock?
Is ARCC stock worth holding onto amid lower-than-expected first-quarter 2025 results, rising expenses, and tariff-related concerns? Let's find out.
|
Thu, 08 May 2025 10:00:00 +0000 |
Hercules Capital Announces Date of 2025 Annual Meeting of Stockholders
SAN MATEO, Calif., May 08, 2025--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), will conduct its 2025 Annual Meeting of Stockholders by virtual meeting on Wednesday, June 18, 2025 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 24, 2025 and mailed to stockholders of record as of April 17, 2025.
|
Fri, 02 May 2025 16:05:00 +0000 |
HTGC's Q1 Earnings Lag Estimates, Total Investment Income Dips
Hercules Capital's first-quarter 2025 earnings narrowly miss estimates due to a dip in total investment income amid a modest rise in expenses.
|
Fri, 02 May 2025 07:19:06 +0000 |
Hercules Capital Inc (HTGC) Q1 2025 Earnings Call Highlights: Strong Portfolio Growth and ...
Hercules Capital Inc (HTGC) reports robust net debt portfolio growth and a successful bond offering, despite slight yield declines and increased nonaccruals.
|
Thu, 01 May 2025 22:30:14 +0000 |
Hercules Capital (HTGC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Hercules Capital (HTGC) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
|
Thu, 01 May 2025 21:25:10 +0000 |
Hercules Capital (HTGC) Q1 Earnings and Revenues Lag Estimates
Hercules Capital (HTGC) delivered earnings and revenue surprises of -2.17% and 1.91%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
|